At Quenet-Torrent Institute we stay at the forefront of oncological research. Our team actively participates in clinical studies that define the future of cancer treatment.
Research
Review published in Clinical and Translational Oncology featuring the contribution of Prof. Luis González Bayón. Cytoreductive surgery in GIST with peritoneal metastases — performed after 6-12 months of TKI therapy and decided in multidisciplinary teams — yields 5-year overall survival rates of up to 80% in carefully selected cases.
Read more
Research
Dr. Pablo Lozano Lominchar, member of the Quenet Torrent team, is the first author of this international consensus with 42 ERAS recommendations graded using GRADE and validated by Delphi between the Spanish Society of Surgeons and the Portuguese Sarcoma Group.
Read more
Research
Pioneering study demonstrating the feasibility and efficacy of a two-stage surgical strategy with HIPEC for voluminous pseudomyxoma peritonei, achieving complete pathological response in all patients with no mortality.
Read more
Research
The PRODIGE 7 study, led by Prof. Dr. François Quenet, provides fundamental data on the role of HIPEC with oxaliplatin in peritoneal carcinomatosis of colorectal origin.
Read moreComplete the form and schedule your appointment to speak directly with the surgeon.